BioAdaptives Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
BioAdaptives Inc. (BDPT) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$129.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-19
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$84.84K.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$97.91K.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$41.18K.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$19.46K.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $20.98K, a 72.65% decline from fiscal 2024.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $76.69K, a 116.83% increase from fiscal 2023.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $35.37K.
- BioAdaptives Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$57.53K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$129.22K 10-Q · filed 2026-08-19 | |||||
| 2026-03-31 | -$84.84K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | $20.98K 10-K · filed 2026-04-14 | |||||
| 2025-09-30 | -$78.20K 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | $73.11K 10-Q · filed 2026-08-19 | |||||
| 2025-03-31 | -$97.91K 10-Q · filed 2026-05-15 | |||||
| 2024-12-31 | $76.69K 10-K · filed 2026-04-14 | |||||
| 2024-09-30 | -$16.88K 10-Q · filed 2025-11-14 | |||||
| 2024-06-30 | -$60.54K 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | -$41.18K 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | $35.37K 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $126.67K 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | $14.72K 10-Q · filed 2024-08-19 | |||||
| 2023-03-31 | -$19.46K 10-Q · filed 2024-05-17 | |||||
| 2022-12-31 | -$57.53K 10-K · filed 2024-04-10 | |||||
| 2022-09-30 | -$63.40K 10-Q · filed 2023-11-13 | -$65.03K 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$38.49K 10-Q · filed 2023-08-11 | -$33.42K 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | -$27.15K 10-Q · filed 2023-05-12 | |||||
| 2021-09-30 | $61.75K 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | $64.93K 10-Q · filed 2022-08-12 |